Position in ESLA
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$15,983
+$11,012 QoQ
Shares Held
15,079
+373.1% QoQ
Ownership
0.035%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ESLA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026UBS Group AG holds $7,583,561,012 across 564 Biotechnology names. ESLA ranks #428 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
22,619,472 | $626,559,372 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
5,177,796 | $545,739,697 | |
| 3 | ABVX |
Abivax S.A.
|
4,547,406 | $506,353,656 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
4,387,677 | $426,615,424 | |
| 5 | INSM |
INSMED Inc
|
1,737,481 | $284,112,890 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
630,618 | $281,596,158 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
299,979 | $231,775,770 | |
| 8 | MRNA |
Moderna, Inc.
|
4,407,907 | $223,921,674 |
All Filings in ESLA
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $15,983 | 15,079 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $4,971 | 3,187 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 ESLAW | — | 1,285 | Shares | Defined | 2025-11-13 | |
| 2025-09-30 | $57,899 | 50,347 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 ESLAW | — | 1,332 | Shares | Defined | 2025-08-14 | |
| 2025-06-30 | $69,861 | 72,773 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 ESLAW | — | 4,453 | Shares | Defined | 2025-05-13 | |
| 2025-03-31 | $38,038 | 41,034 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $78,199 | 65,167 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $7,566 | 6,523 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 ESLAW | — | 5,090 | Shares | Sole | 2024-08-14 | |
| 2023-12-31 | $336 | 303 | Shares | Sole | 2024-02-09 | |
| No filing history on record for this holder in this stock. | ||||||